Itera | $12,000,000 | (May 28, 2026)
ClearNote Health | $52,000,000 | (May 28, 2026)
Protuoso Biosciences | $9,500,000 | (May 28, 2026)
Certified by Founder
Lodge
Sionna Therapeutics
start up
United States
- Boston, MA
- 07/03/2024
- Series C
- $182,000,000
We are a life sciences company that is building on over a decade of extensive research on the genetic mutations associated with cystic fibrosis. We are developing first-in-class small molecules that are focused on a unique target with the potential to fully normalize CFTR function for the first time for the vast majority of people living with CF.
- Industry Biotechnology
- Website https://www.sionnatx.com/
- LinkedIn https://www.linkedin.com/company/sionna-therapeutics/
Fields Good | $1,800,000 | (May 28, 2026)
Cypher AI | $2,000,000 | (May 28, 2026)
C2i Semiconductors | $16,700,000 | (May 28, 2026)
Orbital Industries | $50,000,000 | (May 28, 2026)
Secretome Therapeutics | $30,000,000 | (May 28, 2026)
Pace(US) | $46,000,000 | (May 28, 2026)
Certo | $4,000,000 | (May 28, 2026)
Mykor | $5,360,920 | (May 28, 2026)
Go Swag | $5,000,000 | (May 27, 2026)